GI Medical Oncology Practice Recognized by QOPI Certification Program

Mount Sinai’s Gastrointestinal Medical Oncology practice has been recognized by the Quality Oncology Practice Initiative (QOPI®) Certification Program, an affiliate of the American Society of Clinical Oncology (ASCO).  The QOPI® Certification Program provides a 3-year certification for outpatient hematology-oncology practices that meet the highest standards for quality cancer care.

QOPI certification signifies that an outpatient oncology practice has met core standards in a variety of areas that affect the quality of patient care, including staff training and education, chemotherapy orders and drug preparation, patient consent and education, safe chemotherapy administration, and monitoring and assessment of patient well-being. Mount Sinai is the first site in Manhattan to receive QOPI-certification.

Read more

“Music is Medicine” Visits the Mount Sinai Kravis Children’s Hospital

Music is Medicine is a nonprofit run by a team of college students that pairs artists with pediatric patients through uplifting music programs. Through Music is Medicine’s Donate a Song project, artists write and record original songs for seriously-ill children to inspire the patients, share their stories of strength, and contribute to the greater fight against their diseases.

This past summer, Cindy, a 16 year-old girl battling cancer at the Mount Sinai Kravis Children’s Hospital, met artists Sam Tsui and Elle Winter. The artists then went on to produce an original song called “Unsinkable” for Cindy. In the chorus Sam and Elle sing, “My heart’s unsinkable. Never doubt that things will get better. Can you feel the love? I’m never giving up.” Through the song, Sam and Elle motivate Cindy and people everywhere to never give up. At the same time, all proceeds for the song will benefit pediatric oncology research at Mount Sinai.

Read more

Early Detection of Ovarian Cancer

Ovarian cancer is a heterogeneous and rapidly progressive disease of low prevalence and poor survival. In the United States the number of deaths attributed to ovarian cancer approximates that of all other gynecologic malignancies combined.  Unfortunately, the majority (75%) of women diagnosed with ovarian carcinoma continue to have advanced stage disease (Stage III/ IV), with widespread metastases throughout the peritoneal cavity, lymph nodes, liver or lungs. Presently less than 20% of women with ovarian cancers are detected when the cancer is still confined to the ovary (Stage I).

Read more

Bill Weinzimmer: Advanced Prostate Cancer Survivor

My name is Bill Weinzimmer and I am an advanced  prostate cancer survivor. When I was diagnosed 18 years ago, I was told I only had 18 months to live. Thanks to the amazing care I received from Dr. Simon J. Hall at The Mount Sinai Hospital, and the significant changes I made in my life, I am still alive and active 18 years later at 83-years-young. I hope  my experiences and tips will provide inspiration to others diagnosed with cancer, as well as to their families.

Read more

Cancer Clinical Trials Video Now Online

Today’s standard therapies for cancer exist because people have participated in clinical trials – yet choosing to participate in a cancer clinical trial is an important personal decision that can be intimidating for many patients. In order to better help patients understand cancer clinical trials, the reasons to participate in them, and clinical research at Mount Sinai, The Tisch Cancer Institute has released a new video, “Clinical Trials at Mount Sinai: Moving the Field Forward.”

Read more

Cancer Researcher Ramon E. Parsons, MD, PhD, Joins Mount Sinai

Ramon E. Parsons, MD, PhD, a highly acclaimed researcher in cancer genetics, has joined Icahn School of Medicine at Mount Sinai as the Ward-Coleman Chair in Cancer, and Chair of the Department of Oncological Sciences.

Dr. Parsons succeeds Stuart Aaronson, MD, Jack and Jane B. Aron Professor, whose significant discoveries in molecular oncology include identifying the first normal function of an oncogene, and its role in growth factor signaling. Dr. Aaronson has been appointed Founding Chair Emeritus of the Department of Oncological Sciences, and will continue to lead his highly funded laboratory at Mount Sinai.

Read more